Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herbmed Plus for Ureteral Stent Discomfort
NCT01356355Phase 2Completed
- Start
- Apr 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Herbmed Plus in ureteral stent-related symptoms (USRS) (3 arms). Primary endpoints: Safety of Herbmed plus and tolterodine and Efficacy of Herbmed plus and tolterodine. Started Apr 2012; status: completed.
02
Drugs
Herbmed Plus
03
Conditions
ureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on NCT01356355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01356355.